The selection of β-blocker after successful reperfusion in patients with ST-elevation myocardial infarction.
Ho-Jun JangJon SuhSung Woo KwonSang-Don ParkPyung Chun OhJeonggeun MoonKyounghoon LeeWoong Chol KangIn Hyun JungHyonggin AnTae-Hoon KimPublished in: Perfusion (2019)
Use of a carvedilol in ST-segment myocardial infarction survivor is associated with lower recurrent myocardial infarction events. Thus, it might be the better choice of β-blocker for secondary prevention in ST-elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- acute myocardial infarction
- st segment elevation myocardial infarction
- heart failure
- left ventricular
- acute coronary syndrome
- antiplatelet therapy
- coronary artery disease
- coronary artery bypass grafting
- angiotensin converting enzyme
- coronary artery bypass
- cerebral ischemia
- acute ischemic stroke
- subarachnoid hemorrhage
- brain injury
- blood brain barrier